Diabetes combo drug study pulled before it even started
NCT ID NCT06560333
First seen Dec 24, 2025 · Last updated May 23, 2026 · Updated 22 times
Summary
This study aimed to see if combining two diabetes medications (SGLT2 inhibitor and DPP-4 inhibitor) works better than each drug alone for people with type 2 diabetes whose blood sugar is not well controlled on metformin. It planned to enroll adults aged 18 to 80. However, the study was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Eurofarma Laboratorios S.A
São Paulo, São Paulo, 06696-00, Brazil
Conditions
Explore the condition pages connected to this study.